Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer’s disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be increased in very early disease stages, when neurodegeneration is limited, and can be normal in advanced dise...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 March 2022
|
| In: |
Molecular neurodegeneration
Year: 2022, Jahrgang: 17, Pages: 1-16 |
| ISSN: | 1750-1326 |
| DOI: | 10.1186/s13024-022-00521-3 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13024-022-00521-3
|
| Verfasserangaben: | Pieter Jelle Visser, Lianne M. Reus, Johan Gobom, Iris Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R.J. Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, José Luís Molinuevo, Sebastiaan Engelborghs, Yvonne Freund-Levi, Lutz Froelich, Kristel Sleegers, Valerija Dobricic, Simon Lovestone, Johannes Streffer, Stephanie J.B. Vos, Isabelle Bos, August B. Smit, Kaj Blennow, Philip Scheltens, Charlotte E. Teunissen, Lars Bertram, Henrik Zetterberg, Betty M. Tijms, August B. Smit, Kaj Blennow, Philip Scheltens, Charlotte E. Teunissen, Lars Bertram, Henrik Zetterberg and Betty M. Tijms |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1808808363 | ||
| 003 | DE-627 | ||
| 005 | 20251101220650.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220702s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13024-022-00521-3 |2 doi | |
| 035 | |a (DE-627)1808808363 | ||
| 035 | |a (DE-599)KXP1808808363 | ||
| 035 | |a (OCoLC)1341463401 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Visser, Pieter Jelle |e VerfasserIn |0 (DE-588)1261667328 |0 (DE-627)1808808347 |4 aut | |
| 245 | 1 | 0 | |a Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease |c Pieter Jelle Visser, Lianne M. Reus, Johan Gobom, Iris Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R.J. Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, José Luís Molinuevo, Sebastiaan Engelborghs, Yvonne Freund-Levi, Lutz Froelich, Kristel Sleegers, Valerija Dobricic, Simon Lovestone, Johannes Streffer, Stephanie J.B. Vos, Isabelle Bos, August B. Smit, Kaj Blennow, Philip Scheltens, Charlotte E. Teunissen, Lars Bertram, Henrik Zetterberg, Betty M. Tijms, August B. Smit, Kaj Blennow, Philip Scheltens, Charlotte E. Teunissen, Lars Bertram, Henrik Zetterberg and Betty M. Tijms |
| 264 | 1 | |c 28 March 2022 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.07.2022 | ||
| 520 | |a Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer’s disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be increased in very early disease stages, when neurodegeneration is limited, and can be normal in advanced disease stages. This suggests that t-tau levels may be driven by other mechanisms as well. Because tau pathophysiology is emerging as treatment target for AD, we aimed to clarify molecular processes associated with CSF t-tau levels. | ||
| 650 | 4 | |a Alzheimer's disease | |
| 650 | 4 | |a Biomarker discovery | |
| 650 | 4 | |a Cerebrospinal fluid proteomics | |
| 650 | 4 | |a Heterogeneity | |
| 650 | 4 | |a Molecular mechanisms | |
| 650 | 4 | |a Neuronal plasticity | |
| 700 | 1 | |a Reus, Lianne M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gobom, Johan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kerkmeijer-Jansen, Iris E. |e VerfasserIn |0 (DE-588)1287071023 |0 (DE-627)1843609908 |4 aut | |
| 700 | 1 | |a Dicks, Ellen |e VerfasserIn |4 aut | |
| 700 | 1 | |a van der Lee, Sven J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tsolaki, Magda |e VerfasserIn |4 aut | |
| 700 | 1 | |a Verhey, Frans R. J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Popp, Julius |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martinez-Lage, Pablo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vandenberghe, Rik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lleó, Alberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Molinuevo, José Luís |e VerfasserIn |4 aut | |
| 700 | 1 | |a Engelborghs, Sebastiaan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Freund-Levi, Yvonne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frölich, Lutz |d 1956- |e VerfasserIn |0 (DE-588)1028327099 |0 (DE-627)730567516 |0 (DE-576)375813160 |4 aut | |
| 700 | 1 | |a Sleegers, Kristel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dobricic, Valerija |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lovestone, Simon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Streffer, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vos, Stephanie J. B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bos, Isabelle |e VerfasserIn |4 aut | |
| 700 | 1 | |a Smit, August B. |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Blennow, Kaj |e VerfasserIn |0 (DE-588)1261078578 |0 (DE-627)1913638995 |4 aut | |
| 700 | 1 | |a Scheltens, Philip |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teunissen, Charlotte E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bertram, Lars |e VerfasserIn |4 aut | |
| 700 | 1 | |8 2\p |a Zetterberg, Henrik |e VerfasserIn |0 (DE-588)1261169018 |0 (DE-627)190928758X |4 aut | |
| 700 | 1 | |a Tijms, Betty M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular neurodegeneration |d London : Biomed Central, 2006 |g 17(2022), Artikel-ID 27, Seite 1-16 |h Online-Ressource |w (DE-627)515978361 |w (DE-600)2244557-2 |w (DE-576)260614165 |x 1750-1326 |7 nnas |a Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g elocationid:27 |g pages:1-16 |g extent:16 |a Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease |
| 787 | 0 | 8 | |i Errata |a Visser, Pieter Jelle |t Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease |d 2022 |w (DE-627)1902716833 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13024-022-00521-3 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20250301 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20220702 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1028327099 |a Frölich, Lutz |m 1028327099:Frölich, Lutz |d 60000 |e 60000PF1028327099 |k 0/60000/ |p 16 | ||
| 999 | |a KXP-PPN1808808363 |e 4160303870 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"display":"Visser, Pieter Jelle","family":"Visser","given":"Pieter Jelle","role":"aut"},{"role":"aut","given":"Lianne M.","display":"Reus, Lianne M.","family":"Reus"},{"family":"Gobom","display":"Gobom, Johan","given":"Johan","role":"aut"},{"given":"Iris E.","role":"aut","family":"Kerkmeijer-Jansen","display":"Kerkmeijer-Jansen, Iris E."},{"display":"Dicks, Ellen","family":"Dicks","given":"Ellen","role":"aut"},{"family":"van der Lee","display":"van der Lee, Sven J.","role":"aut","given":"Sven J."},{"role":"aut","given":"Magda","family":"Tsolaki","display":"Tsolaki, Magda"},{"family":"Verhey","display":"Verhey, Frans R. J.","role":"aut","given":"Frans R. J."},{"given":"Julius","role":"aut","display":"Popp, Julius","family":"Popp"},{"role":"aut","given":"Pablo","display":"Martinez-Lage, Pablo","family":"Martinez-Lage"},{"given":"Rik","role":"aut","display":"Vandenberghe, Rik","family":"Vandenberghe"},{"family":"Lleó","display":"Lleó, Alberto","given":"Alberto","role":"aut"},{"family":"Molinuevo","display":"Molinuevo, José Luís","given":"José Luís","role":"aut"},{"display":"Engelborghs, Sebastiaan","family":"Engelborghs","role":"aut","given":"Sebastiaan"},{"given":"Yvonne","role":"aut","display":"Freund-Levi, Yvonne","family":"Freund-Levi"},{"role":"aut","given":"Lutz","display":"Frölich, Lutz","family":"Frölich"},{"given":"Kristel","role":"aut","family":"Sleegers","display":"Sleegers, Kristel"},{"display":"Dobricic, Valerija","family":"Dobricic","given":"Valerija","role":"aut"},{"display":"Lovestone, Simon","family":"Lovestone","role":"aut","given":"Simon"},{"role":"aut","given":"Johannes","family":"Streffer","display":"Streffer, Johannes"},{"role":"aut","given":"Stephanie J. B.","family":"Vos","display":"Vos, Stephanie J. B."},{"given":"Isabelle","role":"aut","family":"Bos","display":"Bos, Isabelle"},{"display":"Smit, August B.","family":"Smit","given":"August B.","role":"aut"},{"family":"Blennow","display":"Blennow, Kaj","role":"aut","given":"Kaj"},{"display":"Scheltens, Philip","family":"Scheltens","given":"Philip","role":"aut"},{"role":"aut","given":"Charlotte E.","display":"Teunissen, Charlotte E.","family":"Teunissen"},{"display":"Bertram, Lars","family":"Bertram","given":"Lars","role":"aut"},{"role":"aut","given":"Henrik","display":"Zetterberg, Henrik","family":"Zetterberg"},{"display":"Tijms, Betty M.","family":"Tijms","given":"Betty M.","role":"aut"}],"recId":"1808808363","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"515978361","id":{"eki":["515978361"],"issn":["1750-1326"],"zdb":["2244557-2"]},"note":["Gesehen am 22.07.2019"],"origin":[{"publisherPlace":"London","publisher":"Biomed Central","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"pubHistory":["1.2006 -"],"title":[{"title_sort":"Molecular neurodegeneration","title":"Molecular neurodegeneration"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s diseaseMolecular neurodegeneration","language":["eng"],"part":{"pages":"1-16","year":"2022","extent":"16","text":"17(2022), Artikel-ID 27, Seite 1-16","volume":"17"}}],"physDesc":[{"extent":"16 S."}],"name":{"displayForm":["Pieter Jelle Visser, Lianne M. Reus, Johan Gobom, Iris Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R.J. Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, José Luís Molinuevo, Sebastiaan Engelborghs, Yvonne Freund-Levi, Lutz Froelich, Kristel Sleegers, Valerija Dobricic, Simon Lovestone, Johannes Streffer, Stephanie J.B. Vos, Isabelle Bos, August B. Smit, Kaj Blennow, Philip Scheltens, Charlotte E. Teunissen, Lars Bertram, Henrik Zetterberg, Betty M. Tijms, August B. Smit, Kaj Blennow, Philip Scheltens, Charlotte E. Teunissen, Lars Bertram, Henrik Zetterberg and Betty M. Tijms"]},"id":{"eki":["1808808363"],"doi":["10.1186/s13024-022-00521-3"]},"title":[{"title_sort":"Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease","title":"Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease"}],"note":["Gesehen am 02.07.2022"],"origin":[{"dateIssuedDisp":"28 March 2022","dateIssuedKey":"2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a VISSERPIETCEREBROSPI2820 | ||